Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inspire Medical Systems (INSP) Net Income (2017 - 2025)

Inspire Medical Systems (INSP) has disclosed Net Income for 9 consecutive years, with $136.0 million as the latest value for Q4 2025.

  • Quarterly Net Income rose 286.23% to $136.0 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $145.3 million through Dec 2025, up 171.7% year-over-year, with the annual reading at $145.4 million for FY2025, 171.77% up from the prior year.
  • Net Income hit $136.0 million in Q4 2025 for Inspire Medical Systems, up from $9.9 million in the prior quarter.
  • In the past five years, Net Income ranged from a high of $136.0 million in Q4 2025 to a low of -$16.8 million in Q3 2022.
  • Historically, Net Income has averaged $4.5 million across 5 years, with a median of -$6.1 million in 2023.
  • Biggest five-year swings in Net Income: surged 369.62% in 2023 and later plummeted 137.27% in 2025.
  • Year by year, Net Income stood at -$2.3 million in 2021, then skyrocketed by 234.44% to $3.2 million in 2022, then soared by 369.62% to $14.8 million in 2023, then surged by 138.11% to $35.2 million in 2024, then surged by 286.23% to $136.0 million in 2025.
  • Business Quant data shows Net Income for INSP at $136.0 million in Q4 2025, $9.9 million in Q3 2025, and -$3.6 million in Q2 2025.